Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4282462
Max Phase: Preclinical
Molecular Formula: C79H100Cl6N10O18S3
Molecular Weight: 1786.64
Molecule Type: Unknown
Associated Items:
ID: ALA4282462
Max Phase: Preclinical
Molecular Formula: C79H100Cl6N10O18S3
Molecular Weight: 1786.64
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)CCC(CCC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)(CC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)NC(=O)CCC(=O)O)c2)C1
Standard InChI: InChI=1S/C79H100Cl6N10O18S3/c1-93-47-65(62-40-56(80)43-71(83)68(62)50-93)53-7-4-10-59(37-53)114(102,103)89-22-28-111-34-31-108-25-19-86-74(96)15-17-79(92-76(98)13-14-78(100)101,46-77(99)88-21-27-110-33-36-113-30-24-91-116(106,107)61-12-6-9-55(39-61)67-49-95(3)52-70-64(67)42-58(82)45-73(70)85)18-16-75(97)87-20-26-109-32-35-112-29-23-90-115(104,105)60-11-5-8-54(38-60)66-48-94(2)51-69-63(66)41-57(81)44-72(69)84/h4-12,37-45,65-67,89-91H,13-36,46-52H2,1-3H3,(H,86,96)(H,87,97)(H,88,99)(H,92,98)(H,100,101)/t65-,66-,67-/m0/s1
Standard InChI Key: XBKAEYJNKRIMLA-HAVWHVHFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1786.64 | Molecular Weight (Monoisotopic): 1782.4510 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2016) Nhe3-binding compounds and methods for inhibiting phosphate transport, |
Source(1):